Related Experiment Video
Updated: Mar 10, 2026

05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
4.8K
Neural activity, memory, and dementias: serotonergic markers
1Pharmacobiology Departament, CINVESTAV. Mexico City, Mexico.
Behavioural Pharmacology
|December 8, 2016
Summary
Memory dysfunction in dementia may be treatable by targeting serotonin pathways. Neural markers like serotonin receptors and transporters offer potential therapeutic targets for improving memory and cognitive function.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Memory dysfunction is a core symptom of dementias and neuropsychiatric disorders.
- Effective treatments are lacking due to the absence of reliable neural biomarkers.
- The serotonin (5-hydroxytryptamine or 5-HT) system is implicated in memory processes.
Purpose of the Study:
- To explore the role of the serotonin system as a source of neural biomarkers for memory dysfunction.
- To identify potential therapeutic targets within the serotonin system for treating memory deficits.
Main Methods:
- Review of existing literature on serotonergic mechanisms in memory.
- Analysis of neural markers, including serotonin receptors (5-HT1-7) and transporters.
- Examination of the bidirectional relationship between memory processes and serotonergic markers.
Main Results:
- Serotonin receptors (e.g., 5-HT1A, 5-HT4, 5-HT6, 5-HT7) and the serotonin transporter are present in memory-related brain areas.
- These markers are altered by memory, amnesia, and forgetting.
- Specific receptors (5-HT2A/2B/2C, 5-HT4, 5-HT6) are linked to tau hyperphosphorylation in Alzheimer's disease.
Conclusions:
- Serotonergic neural markers represent promising targets for therapeutic intervention in memory disorders.
- Modulating the serotonin system may offer a strategy to reverse or reduce memory deficits in dementia.
- Synaptic plasticity, crucial for memory, involves changes in neurotransmitter receptors and transporters.
Related Concept Videos
Role of Neurotransmitters in Memory
2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K

